“Cervical intraepithelial neoplasia”的搜索结果，显示 721-730 项，共有 15497 项

1. 神经外科- 临床试验- 妙佑医疗国际

   :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...

3. 外科 - 临床试验- 妙佑医疗国际

   ... cancer tumor presence in a sample of up to 250 residual skin specimens. ... Researchers at Mayo Clinic are developing a Biobank of adult stem cell-rich breast ...

4. 乳腺癌- 医生与科室- 妙佑医疗国际

   Breast cancer, Cervical cancer, Ovarian cancer, Endometrial cancer, Peritoneal cancer, BRCA gene mutation, Male breast ...cancer. 显示更多擅长领域 针对 ...

5. 膀胱癌- 医生与科室- 妙佑医疗国际

   Connect with others like you for support and answers to your questions in the Cancer support group on Mayo Clinic Connect, a patient community. Cancer ...

6. 神经科- 临床试验- 妙佑医疗国际

   :Cohort 1 includes (1) advanced unresectable pancreatic cancer, (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype: triple negative ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Researchers at Mayo Clinic are developing a Biobank of adult stem cell-rich breast organoids, a new research resource to facilitate normal and cancer stem cell ...

9. 头颈癌- 医生与科室- 妙佑医疗国际

   Connect with others like you for support and answers to your questions in the Head & Neck Cancer support group on Mayo Clinic Connect, a patient community. Head ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... cancer and small cell lung cancer. Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and ...